![](/img/cover-not-exists.png)
Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial
Davids, Matthew S, Brander, Danielle M, Kim, Haesook T, Tyekucheva, Svitlana, Bsat, Jad, Savell, Alexandra, Hellman, Jeffrey M, Bazemore, Josie, Francoeur, Karen, Alencar, Alvaro, Shune, Leyla, OmairaLanguage:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(19)30104-8
Date:
June, 2019
File:
PDF, 346 KB
english, 2019